Pharmaceutical pharma and related areas including drug are generating substantial coverage, with recent headlines pointing to active developments around drugs. The Latest Pharma News section brings together the most relevant updates for professionals and stakeholders tracking this segment.
This section aggregates reporting from SCOTUSblog, The Economic Times, BioSpectrum Asia, and other trusted industry sources. It offers a consolidated view of breaking news, policy updates, and announcements relevant to pharma and related developments.
Readers seeking deeper context may consult Biotechnology Industry Research Assistance Council for regulatory information and Nature Biotechnology for sector analysis and data. For research literature, IQVIA Biotech Intelligence provides access to peer-reviewed publications on relevant topics.
Showing 30 articles
-
Justices reject holding generic pharmaceutical manufacturers liable for decisions of pharmacists about prescribing their products
Justices reject holding generic pharmaceutical manufacturers liable for decisions of pharmacists about prescribing their products SCOTUSblog
-
Regulator, cos discuss price hike for some cancer drugs
Regulator, cos discuss price hike for some cancer drugs The Economic Times
-
SGS Acquires CMIC to Expand North American Bioanalytical Testing Capabilities
SGS Acquires CMIC to Expand North American Bioanalytical Testing Capabilities BioSpectrum Asia
-
PharmTech Weekly Roundup—June 5, 2026
PharmTech Weekly Roundup—June 5, 2026 PharmTech.com
-
Arihant Innochem launches Research and Innovation Centre in Navi Mumbai
Arihant Innochem launches Research and Innovation Centre in Navi Mumbai Express Pharma
-
ALVO Stock Gains 19% on FDA Resubmission of Biosimilar BLAs
ALVO Stock Gains 19% on FDA Resubmission of Biosimilar BLAs TradingView
-
Parabilis eyes $475m IPO to push lead asset into Phase III
Parabilis eyes $475m IPO to push lead asset into Phase III Pharmaceutical Technology
-
Wanbury FY26 PAT surges 117% to Rs. 66.1 crore
Wanbury FY26 PAT surges 117% to Rs. 66.1 crore Indian Pharma Post
-
Tom Sellig on CDMO Innovation and US Manufacturing Growth
Tom Sellig on CDMO Innovation and US Manufacturing Growth PharmTech.com
-
Pharma, patients seek clarity on new vouchers
Pharma, patients seek clarity on new vouchers Politico
-
Muthukumar Anbalagan joins Intas Pharma as General Manager – NDDS
Muthukumar Anbalagan joins Intas Pharma as General Manager – NDDS Indian Pharma Post
-
데일리팜코리아, 데일리팜 영문뉴스, dailypharmkorea
데일리팜코리아, 데일리팜 영문뉴스, dailypharmkorea 데일리팜
-
An inconvenient truth? Japan, innovation, drug pricing, MFN
An inconvenient truth? Japan, innovation, drug pricing, MFN The Pharma Letter
-
Teva Pharmaceuticals Highlights Real-World Survey Data Showing Impact of Huntington's Disease Chorea on Patients and Caregivers
Teva Pharmaceuticals Highlights Real-World Survey Data Showing Impact of Huntington's Disease Chorea on Patients and Caregivers Quiver Quantitative
-
GLP-1 Drugs Projected to Reach $150B in Sales by 2030, Boosting LLY and NVO
GLP-1 Drugs Projected to Reach $150B in Sales by 2030, Boosting LLY and NVO GuruFocus
-
4 Biotech Stocks Investors Should Watch in 2026
4 Biotech Stocks Investors Should Watch in 2026 TradingView
-
Lilly and Boehringer pause $2bn German investments over planned drug-spending curbs
Lilly and Boehringer pause $2bn German investments over planned drug-spending curbs European Biotechnology Magazine
-
Q&A: Why Pharma Supply Chains Are Turning to AI
Q&A: Why Pharma Supply Chains Are Turning to AI Pharmaceutical Commerce
-
Are pharma teams ready for the next customer engagement model?
Are pharma teams ready for the next customer engagement model? pharmaphorum
-
Russia aims to have generic of one of the most expensive cystic fibrosis drugs
Russia aims to have generic of one of the most expensive cystic fibrosis drugs The Pharma Letter
-
PJP vs XBI: Pharmaceutical vs Biotech ETF Comparison for Investors - News and Statistics
PJP vs XBI: Pharmaceutical vs Biotech ETF Comparison for Investors - News and Statistics IndexBox
-
Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI
Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI Pharmaceutical Executive
-
데일리팜코리아, 데일리팜 영문뉴스, dailypharmkorea
데일리팜코리아, 데일리팜 영문뉴스, dailypharmkorea 데일리팜
-
Healthcare ETFs: PJP Focuses on Pharmaceuticals, While XBI Zeroes in on Biotech
Healthcare ETFs: PJP Focuses on Pharmaceuticals, While XBI Zeroes in on Biotech The Motley Fool
-
Korea's Daewoong Pharma partners with China's Chime Biologics for Dupixent biosimilar development
Korea's Daewoong Pharma partners with China's Chime Biologics for Dupixent biosimilar development BioSpectrum Asia
-
WuXi Biologics Tops Out Modular Drug Product Facility in Singapore
WuXi Biologics Tops Out Modular Drug Product Facility in Singapore Contract Pharma
-
FAQ: What Does the Medicare GLP-1 Bridge Mean for Pharma?
FAQ: What Does the Medicare GLP-1 Bridge Mean for Pharma? Pharmaceutical Commerce
-
India's ₹12 Lakh Crore Pharma Powerhouses: The Companies Defining Global Healthcare in 2026
India's ₹12 Lakh Crore Pharma Powerhouses: The Companies Defining Global Healthcare in 2026 eHealth Magazine
-
Gilead Sciences, Lakefront Biotherapeutics Acquire Ouro Medicines
Gilead Sciences, Lakefront Biotherapeutics Acquire Ouro Medicines Contract Pharma
-
Teva expands European biosimilars push with AHZANTIVE launch for eye disease treatment
Teva expands European biosimilars push with AHZANTIVE launch for eye disease treatment Indian Pharma Post